tuberculosis - Nursing Case Study
Pathophysiology
• Primary mechanism: Tuberculosis is caused by the bacterium Mycobacterium tuberculosis, which primarily infects the lungs. Upon inhalation, the bacteria are engulfed by alveolar macrophages but resist destruction due to their waxy cell wall, leading to intracellular survival and replication.
• Secondary mechanism: The immune response forms granulomas, where macrophages, T-cells, and other immune cells encase the bacteria. While granulomas contain the infection, a weakened immune system can cause them to break down, leading to active disease and tissue damage.
• Key complication: Reactivation of latent TB can occur when immune defenses are compromised, resulting in the spread of bacteria and extensive lung damage, with symptoms such as chronic cough, hemoptysis, and systemic effects like fever and weight loss.
Patient Profile
Demographics:
35-year-old male, construction worker
History:
• Key past medical history: Previously treated for latent TB infection 5 years ago, history of smoking (10 pack-years)
• Current medications: None
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent cough and fatigue for 3 weeks
• Key symptoms: Night sweats, weight loss of 5 kg over the past month, hemoptysis, chest pain
• Vital signs: Temperature 38.5°C (101.3°F), heart rate 110 bpm, respiratory rate 24 breaths/min, blood pressure 100/65 mmHg
Section 1
As part of the initial assessment in the emergency department, the 35-year-old male underwent a thorough physical examination and diagnostic workup. On auscultation, diminished breath sounds, crackles, and bronchial breathing were noted in the upper lobes of the lungs, suggesting the presence of pulmonary consolidation. A chest X-ray revealed bilateral upper lobe cavitary lesions, characteristic of active pulmonary tuberculosis, along with hilar lymphadenopathy. These findings were consistent with reactivated TB, likely due to the patient's history of latent TB and potential immune compromise from his smoking history.
Laboratory results showed elevated inflammatory markers, with a C-reactive protein level of 120 mg/L and an elevated erythrocyte sedimentation rate (ESR) of 70 mm/hr, indicating significant inflammation. Sputum samples were collected for acid-fast bacilli (AFB) staining and culture, with preliminary results returning positive for AFB, confirming active TB infection. The patient also underwent a complete blood count, which revealed mild anemia (hemoglobin 11 g/dL) and leukocytosis (white blood cell count of 14,500 cells/mm³), further supporting an infectious process.
Given these findings, the clinical team initiated a standard anti-tuberculosis regimen, taking into account the patient's penicillin allergy, and arranged for respiratory isolation to prevent transmission. The patient was educated about the importance of medication adherence and potential side effects. However, despite starting treatment, the patient began experiencing worsening dyspnea and a persistent increase in respiratory rate to 28 breaths/min over the following days, suggesting the development of a new complication, such as a pleural effusion or pneumothorax, warranting immediate reevaluation and possible intervention.
Section 2
As the patient's respiratory status worsened, the healthcare team decided to perform a repeat chest X-ray and a thoracic ultrasound to investigate the cause of his increasing dyspnea and elevated respiratory rate. The repeat chest X-ray showed a new right-sided pleural effusion, which was confirmed by the ultrasound to be moderate in size. This finding suggested that the effusion could be contributing to his respiratory distress. Given his history and current presentation, it was hypothesized that the effusion might be a tuberculous pleuritis, a common complication of pulmonary tuberculosis.
The patient's vital signs showed a respiratory rate of 28 breaths/min, heart rate of 110 beats/min, blood pressure of 130/85 mmHg, and oxygen saturation of 90% on room air, now requiring supplemental oxygen to maintain adequate saturation. The clinical team decided to perform a therapeutic thoracentesis to relieve the patient's symptoms and obtain fluid for analysis. The procedure yielded 500 mL of straw-colored fluid, which was sent for biochemical, cytological, and microbiological analysis. The pleural fluid analysis revealed a high protein content and low glucose levels, with lymphocyte predominance on cytology, further supporting a diagnosis of tuberculous pleuritis. Acid-fast bacilli were also detected in the pleural fluid, confirming the involvement of TB in the effusion.
Following the thoracentesis, the patient's respiratory symptoms improved significantly, with a decrease in respiratory rate to 22 breaths/min and improved oxygen saturation to 94% on room air. The team adjusted the anti-tuberculosis regimen to include adjunct corticosteroids to address the pleural inflammation, as per current guidelines. The patient was counseled about the importance of continued medication adherence and regular follow-up to monitor for further complications. The next steps involved close monitoring of the patient's response to the adjusted treatment regimen and planning for discharge once his condition stabilized, with continued outpatient follow-up to ensure complete resolution of the tuberculosis infection.
Section 3
As the patient continued his recovery, the healthcare team closely monitored his response to the adjusted anti-tuberculosis regimen and corticosteroid therapy. Over the following days, his vital signs showed further improvement, with a respiratory rate of 20 breaths/min, heart rate of 98 beats/min, blood pressure of 125/80 mmHg, and oxygen saturation of 96% on room air. The patient reported feeling less fatigued and noted a decrease in his dyspnea. Encouraged by these positive signs, the team considered the possibility of transitioning him to oral medications and preparing for discharge.
Despite the initial positive response, the patient began exhibiting new symptoms, including a persistent low-grade fever and night sweats, which were not present before. Laboratory tests revealed a mild leukocytosis with a white blood cell count of 12,000/mm³ and an elevated C-reactive protein level, suggesting an inflammatory process still at play. Given these findings, the clinical reasoning process involved considering whether these symptoms could represent a paradoxical reaction to therapy, a known but often overlooked complication in tuberculosis treatment. This phenomenon, sometimes seen with TB treatment, can cause a temporary worsening of symptoms as the immune system mounts a response against the remaining bacteria.
To address this, the healthcare team decided to maintain the corticosteroid therapy while reassessing the patient's antibiotic regimen to ensure optimal coverage. Additional imaging, including a follow-up chest X-ray, showed no new lesions or significant changes in the pleural effusion. This provided reassurance that the pleural effusion was resolving. The team emphasized the importance of continued adherence to the medication regimen and scheduled a follow-up appointment for further evaluation. As the patient prepared for discharge, education focused on recognizing signs of potential complications and the importance of immediate medical attention if symptoms worsened, ensuring proactive management of his condition during outpatient care.
Section 4
In the days following discharge, the patient initially adhered well to the prescribed oral medication regimen, maintaining a diligent schedule and attending follow-up appointments. However, during a routine outpatient visit two weeks post-discharge, he reported experiencing increased coughing and a recurrence of night sweats. He also mentioned feeling more fatigued than usual, prompting concern from the healthcare team. Physical examination revealed diminished breath sounds in the right lower lung field, and his vital signs showed a slight increase in respiratory rate to 24 breaths/min with an oxygen saturation of 93% on room air, indicating a possible decline in respiratory function.
Given these changes, the team decided to conduct further diagnostic tests to assess the underlying cause of the symptoms. A repeat chest X-ray revealed a new consolidation in the right lower lobe, raising suspicion of a secondary bacterial infection or a possible reactivation of the tuberculosis infection. Laboratory tests showed an increased white blood cell count of 14,500/mm³ and elevated inflammatory markers, including a C-reactive protein level of 50 mg/L. These findings suggested an active inflammatory or infectious process that required immediate attention.
Acknowledging the potential for secondary complications in a patient with recent tuberculosis treatment, the healthcare team initiated a targeted antibiotic therapy to address the suspected bacterial pneumonia. They also adjusted the anti-tuberculosis regimen to ensure comprehensive coverage and prevent further deterioration. The patient's response to these interventions would be closely monitored, with plans for regular follow-up visits and additional imaging if symptoms persisted or worsened. The focus remained on the importance of medication adherence and monitoring for any new or worsening symptoms, emphasizing a proactive approach to managing the patient's complex condition.
Section 5
Two weeks after initiating the targeted antibiotic therapy and adjusting the anti-tuberculosis regimen, the patient returned for a follow-up appointment. Despite initial signs of improvement, he reported experiencing new symptoms, including shortness of breath and chest tightness, especially during physical activity. His family also noted that he appeared more lethargic and had difficulty completing daily tasks. During the physical examination, the healthcare team noted an increased respiratory rate of 28 breaths/min and a further drop in oxygen saturation to 89% on room air. Auscultation of the lungs revealed diffuse crackles in addition to the previously noted diminished breath sounds in the right lower lung field. Concerned about these findings, the team decided to conduct a thorough reassessment.
A repeat chest X-ray and high-resolution CT scan of the chest were ordered to evaluate the patient's pulmonary status more comprehensively. The imaging results showed an increase in the size of the consolidation in the right lower lobe, along with new bilateral infiltrates, suggesting a progression of the pulmonary condition. Lab tests revealed a persistent elevation in white blood cell count at 16,000/mm³ and a C-reactive protein level of 70 mg/L, indicating ongoing inflammation. Additionally, arterial blood gas analysis showed a pH of 7.32, PaCO2 of 50 mmHg, and PaO2 of 55 mmHg, consistent with respiratory acidosis and hypoxemia, further highlighting the patient's respiratory compromise.
These findings raised concerns about the development of acute respiratory distress syndrome (ARDS) as a complication of the underlying infections. The healthcare team promptly initiated supplemental oxygen therapy and considered the need for non-invasive positive pressure ventilation to improve oxygenation. The decision was also made to consult a pulmonologist to explore potential advanced interventions and refine the treatment plan. The patient's response to these enhanced interventions would be closely monitored, with a focus on stabilizing his respiratory status and preventing further complications.